Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from GlaxoSmithKline ( (GB:GSK) ).
GSK has granted a notional Ordinary Share award to Roanne Parry under its Deferred Investment Award programme, following her appointment as Chief People Officer and a new member of the Executive Committee. The award is structured to vest over several years, aligning her incentives with long‑term shareholder interests and reinforcing the company’s focus on retention and leadership stability.
Under the plan, dividends accrue on the notional shares during the vesting period, with payment ultimately made in cash rather than equity. The award vests in two tranches in 2028 and 2029, and is forfeitable if Parry resigns or is terminated for cause, while executive directors remain ineligible for this programme, underscoring its targeted use for specific senior leaders.
The most recent analyst rating on (GB:GSK) stock is a Buy with a £26.30 price target. To see the full list of analyst forecasts on GlaxoSmithKline stock, see the GB:GSK Stock Forecast page.
Spark’s Take on GSK Stock
According to Spark, TipRanks’ AI Analyst, GSK is a Neutral.
The score is driven by solid underlying financial performance and attractive valuation (moderate P/E and healthy dividend). These positives are tempered by weak technical momentum (below major moving averages with negative MACD) and earnings-call-flagged risks like FX headwinds and launch/execution ramp timing, despite constructive 2026 guidance.
To see Spark’s full report on GSK stock, click here.
More about GlaxoSmithKline
GSK is a global biopharma company focused on uniting science, technology and talent to develop medicines and vaccines that help people get ahead of disease. The company operates internationally with a portfolio spanning pharmaceuticals and other biopharmaceutical products aimed at major therapeutic areas and public health needs.
Average Trading Volume: 9,291,947
Technical Sentiment Signal: Buy
Current Market Cap: £75.89B
For an in-depth examination of GSK stock, go to TipRanks’ Overview page.